"We're living longer and we need new parts. We're very excited about this agreement, especially considering the tremendous potential of the medical prosthetics market. The bottom line is that dental implants are just the tip of the iceberg of what is estimated to be a $20 billion annual market."
ALBUQUERQUE, N.M.--Manhattan Scientifics, Inc. (OTC: MHTX) announced that at today's historic press conference introducing the use of the first FDA-approved dental implant made with nanotitanium, the company will sign a letter of intent with NanoMet, the Russian enterprise that helped create nanotitanium (titanium on steroids) to participate in the distribution of dental implants in Russia. The dental implants will be manufactured by Basic Dental Inc., the Albuquerque-based manufacturer of America's first nanotitanium dental implants, which possess the ability to bond more quickly to human bone and promote faster healing.
Manhattan Scientifics Founder Marvin Maslow said, "We're living longer and we need new parts. We're very excited about this agreement, especially considering the tremendous potential of the medical prosthetics market. The bottom line is that dental implants are just the tip of the iceberg of what is estimated to be a $20 billion annual market."
For more information and detail, please read today's Forbes.com story titled, Using Cold War Tech for Peacetime Healing (http://www.forbes.com/2010/10/14/weapons-healthcare-implants-technology-nanotitanium.html).
The dental implant is manufactured and distributed by Basic Dental Inc. of Albuquerque, under a limited license from Manhattan Scientifics, who also issued a broader exclusive license to a major Fortune /1000 U.S. NYSE metals manufacturing company to cover other medical and non-medical applications for the new class of super strong / super light metals.
Manhattan Scientifics, Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.